ViewLux provides today's leading option for 1536-well plates, and will support higher density plates, when they become available. Using 1536-well plates and, for example, fluorescence intensity, ViewLux can allow throughputs in excess of 200,000 samples per hour under continuous operation. Typical processing times for fluorescence polarization assays (including plate movement and data handling) are less than 90 seconds per plate.
The ViewLux is based on sophisticated imaging technology. The detector is a Peltier-cooled CCD camera coupled to an optimized telecentric optical lens. The camera is a back illuminated CCD operating at -100º Celsius. For epi-fluorescence excitation there is an extremely powerful array of flash-lamps together with high-quality optics. Furthermore, the instrument supports both robot loading and batch mode operation. Up to 64 plates can be loaded for unattended operation. Users can alternate between batch and robot loading according to needs. For protocol and plate identification, bar code readers are set to read from the short and long edges of the plate. The ViewLux Workstation software is compatible with Windows NT. It allows full control over image acquisition and image display. Results are automatically stored in the ViewLux database and can then be exported for analysis by other applications.
The sole source determination is based on the fact that PerkinElmer is the sole distributor for the ViewLux Microplate Imager 1430-0010A and no other product will fulfill the Government's need. In addition, the use of this vendor is imperative in order to be compatible with existing units
PRODUCT DESCRIPTION:
Qty-1, ViewLux ultra HTS Microplate Imager 1430-0010A
This acquisition is being conducted under FAR Part 13, Simplified Acquisition Procedures, and is exempt from the requirements of FAR Part 6, Competition Requirements. The North American Industry Classification (NAICS) Code is 334516 and the Size Standard is 500 Employees. This notice of intent is not a request for competitive proposals. The determination by the Government not to compete the proposed purchase order based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing synopsis number NHLBI-CSB-(HG)-2011-075-RSF may be submitted by mail to the National Heart, Lung and Blood Institute, Office of Acquisitions, 6701 Rockledge Drive, Suite 6151, Bethesda, MD 20892-7902, Attention: Rashida Ferebee, by fax transmission to (301) 480-3345 or by email to [email protected]
This action is under the authority of 41.U.S.C.253(c)(1), as set forth in FAR 13.106-1(b)(2), and HHSAR 306-302-1. Interested parties responding to this announcement need to do so by 9:00am Eastern Standard Time on January 31, 2011.